GH Research PLC

NasdaqGM:GHRS Rapporto sulle azioni

Cap. di mercato: US$597.3m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

GH Research Gestione

Gestione criteri di controllo 1/4

GH Research's Il CEO è Theis Terwey, nominato in May2021, ha un mandato di 3.25 anni. possiede direttamente 11.89% delle azioni della società, per un valore di $ 61.88M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.9 anni e 3.3 anni.

Informazioni chiave

Theis Terwey

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO3.3yrs
Proprietà del CEO11.9%
Durata media del management1.9yrs
Durata media del Consiglio di amministrazione3.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

We're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wisely

Jun 21
We're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wisely

GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

Mar 01
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

Nov 17
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

Jul 30
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wisely

Mar 13
We're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wisely

Companies Like GH Research (NASDAQ:GHRS) Are In A Position To Invest In Growth

Nov 28
Companies Like GH Research (NASDAQ:GHRS) Are In A Position To Invest In Growth

GH Research GAAP EPS of $0.006

Aug 23

We Think GH Research (NASDAQ:GHRS) Can Afford To Drive Business Growth

Aug 15
We Think GH Research (NASDAQ:GHRS) Can Afford To Drive Business Growth

GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

Apr 29
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About GH Research's (NASDAQ:GHRS) Cash Burn Rate

Jan 13
We're Not Very Worried About GH Research's (NASDAQ:GHRS) Cash Burn Rate

GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

Sep 30
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans

GH Research: A Recent IPO Stock That Could Possibly Be A Trailblazer In A Hot Industry

Aug 15

AMMINISTRATORE DELEGATO

Theis Terwey (48 yo)

3.3yrs

Mandato

Dr. Theis Terwey, MD, PD, Dr. Med, is Chief Executive Officer at GH Research PLC since May 2021. He co-founded GH Research PLC in 2018 and was its Director from 2018 to 2020. Dr. Terwey also served as a Se...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Florian Schonharting
Co-Founder & Non-Executive Chairman of the Board6.6yrsNessun dato28.49%
$ 170.2m
Theis Terwey
Co-Founder & CEO3.3yrsNessun dato11.89%
$ 71.0m
Magnus Halle
Co-Founder & MD of Irelandno dataNessun datoNessun dato
Julie Ryan
Vice President of Finance3.6yrsNessun datoNessun dato
Aaron Cameron
Chief Operating Officerless than a yearNessun datoNessun dato
Velichka Valcheva
Chief Medical Officerless than a yearNessun datoNessun dato

1.9yrs

Durata media

43.5yo

Età media

Gestione esperta: Il team dirigenziale di GHRS non è considerato esperto (durata media 1.9 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Florian Schonharting
Co-Founder & Non-Executive Chairman of the Board6.6yrsNessun dato28.49%
$ 170.2m
Michael Forer
Independent Vice Chairman3.7yrsNessun dato0.41%
$ 2.4m
Dermot Hanley
Independent Non-Executive Director2.9yrsNessun datoNessun dato
Duncan Moore
Independent Non-Executive Director2.9yrsNessun datoNessun dato

3.3yrs

Durata media

58.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di GHRS sono considerati esperti (durata media dell'incarico 3.3 anni).